The diversity of molecular pathways requiring SETD2's methylating activity underscores the enzyme's crucial role in maintaining cellular homeostasis and warrants further investigation into molecular networks involving SETD2 that drive ccRCC oncogenesis. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.